Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

spectrin α I Inhibitors

The class of compounds known as Spectrin α I inhibitors encompasses a diverse group of chemical agents that are primarily characterized by their ability to modulate the interactions and functions of spectrin α subunits within the cytoskeletal framework of cells. Spectrins are crucial components of the cell's structural scaffold, forming a network that supports cell shape, mechanical stability, and intracellular organization. Spectrin α subunits play a pivotal role in connecting the actin cytoskeleton to the plasma membrane, thereby contributing to the maintenance of cell integrity and shape. The inhibitors within this class operate by targeting different molecular components and pathways associated with spectrin α I subunits and their interactions with other cytoskeletal elements.These inhibitors exhibit various mechanisms of action, including disrupting the binding between spectrin α I and its interacting partners, such as ankyrin and actin. By perturbing these interactions, these inhibitors can lead to alterations in the cytoskeletal organization and membrane-cytoskeleton linkage.

Some inhibitors within this class competitively inhibit the binding of ankyrin to spectrin α I, weakening the connections that anchor the spectrin network to the membrane. Others interfere with actin polymerization or stability, indirectly influencing the arrangement of the spectrin-actin cytoskeletal meshwork. Furthermore, some inhibitors directly target enzymes or molecular pathways that impact spectrin's role in maintaining cellular structure, such as calpain proteases that cleave spectrin, leading to membrane instability. In summary, Spectrin α I inhibitors form a chemically diverse category of compounds that impede the normal interactions and functions of spectrin α I subunits within the intricate cytoskeletal framework of cells. Through a variety of mechanisms, these inhibitors alter the connections between spectrin and its binding partners or modulate the stability and organization of the actin-spectrin network. This disruption of normal cellular architecture can have a notable impact on cell shape, mechanics, and intracellular organization.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Calpeptin

117591-20-5sc-202516
sc-202516A
10 mg
50 mg
$121.00
$456.00
28
(1)

Inhibits calpain proteases, preventing their cleavage of spectrin and other cytoskeletal proteins, thereby maintaining cell membrane integrity.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Binds to actin monomers, preventing their polymerization, and disrupting the actin-spectrin cytoskeletal network, leading to cell deformability changes.

(±)-Blebbistatin

674289-55-5sc-203532B
sc-203532
sc-203532A
sc-203532C
sc-203532D
5 mg
10 mg
25 mg
50 mg
100 mg
$183.00
$313.00
$464.00
$942.00
$1723.00
7
(1)

Inhibits myosin II ATPase activity, disrupting the actomyosin contractility and impacting the interaction between spectrin and actin.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Inhibits Rho-associated protein kinase (ROCK), leading to altered actin cytoskeleton dynamics and potential downstream effects on spectrin organization.

CK 666

442633-00-3sc-361151
sc-361151A
10 mg
50 mg
$321.00
$1040.00
5
(0)

Disrupts the Arp2/3 complex-mediated actin branching, affecting the actin-spectrin meshwork organization at the cell periphery.

Phalloidin

17466-45-4sc-202763
1 mg
$234.00
33
(1)

Stabilizes actin filaments, leading to changes in the actin-spectrin network and impacting cell mechanical properties.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Inhibits actin polymerization, affecting the integrity of the actin-spectrin cytoskeleton and altering cell shape and deformability.